207 related articles for article (PubMed ID: 20973164)
21. Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma.
Sauer S
Trends Pharmacol Sci; 2015 Oct; 36(10):688-704. PubMed ID: 26435213
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
Park SJ; Lee YC
J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
Luconi M; Cantini G; Serio M
Steroids; 2010; 75(8-9):585-94. PubMed ID: 19900469
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome Proliferator-activated Receptor-γ As A Novel and Promising Target For Treating Cancer Via Regulation of Inflammation: A Brief Review.
Yuvaraj S; Kumar BRP
Mini Rev Med Chem; 2022; 22(1):3-14. PubMed ID: 33888047
[TBL] [Abstract][Full Text] [Related]
25. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
26. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
27. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
Omeragic A; Hoque MT; Choi UY; Bendayan R
J Neuroinflammation; 2017 Sep; 14(1):183. PubMed ID: 28886715
[TBL] [Abstract][Full Text] [Related]
29. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
30. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation.
Witte N; Muenzner M; Rietscher J; Knauer M; Heidenreich S; Nuotio-Antar AM; Graef FA; Fedders R; Tolkachov A; Goehring I; Schupp M
Endocrinology; 2015 Nov; 156(11):4008-19. PubMed ID: 26181104
[TBL] [Abstract][Full Text] [Related]
31. PPAR gamma gene--a review.
Janani C; Ranjitha Kumari BD
Diabetes Metab Syndr; 2015; 9(1):46-50. PubMed ID: 25450819
[TBL] [Abstract][Full Text] [Related]
32. Dietary modulation of peroxisome proliferator-activated receptor gamma.
Marion-Letellier R; Déchelotte P; Iacucci M; Ghosh S
Gut; 2009 Apr; 58(4):586-93. PubMed ID: 19017686
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
Wang Q; Imam MU; Yida Z; Wang F
Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
[TBL] [Abstract][Full Text] [Related]
34. Anti-leukemic effects of PPARγ ligands.
Ryu S; Kim DS; Lee MW; Lee JW; Sung KW; Koo HH; Yoo KH
Cancer Lett; 2018 Apr; 418():10-19. PubMed ID: 29331412
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
36. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
Awais M; Sato M; Umezawa Y
Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-γ is expressed in eosinophils in nasal polyps.
Asaka C; Honda K; Ito E; Fukui N; Chihara J; Ishikawa K
Int Arch Allergy Immunol; 2011; 155 Suppl 1():57-63. PubMed ID: 21646797
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome Proliferator-Activated Receptor (PPARγ) Plays a Protective Role in Cigarette Smoking-Induced Inflammation via AMP-Activated Protein Kinase (AMPK) Signaling.
Wang L; Yin Y; Hou G; Kang J; Wang Q
Med Sci Monit; 2018 Jul; 24():5168-5177. PubMed ID: 30044769
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism.
Cantini G; Lombardi A; Borgogni E; Francalanci M; Ceni E; Degl'Innocenti S; Gelmini S; Poli G; Galli A; Serio M; Forti G; Luconi M
Eur J Cell Biol; 2010 Sep; 89(9):645-53. PubMed ID: 20537761
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand.
Itoh T; Yamamoto K
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):541-7. PubMed ID: 18193404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
